KMB vs PG

For growth investors, The Procter & Gamble Company (PG) is the stronger pick with 0.

3% revenue growth year-over-year, versus -14. 2% for Kimberly-Clark Corporation (KMB). Kimberly-Clark Corporation (KMB) offers the better valuation at 16. 3x trailing P/E (13. 2x forward), making it the more compelling value choice. Analysts rate The Procter & Gamble Company (PG) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Kimberly-Clark Corporation (KMB) is the cheapest at 16.

3x versus The Procter & Gamble Company at 22. 7x. On forward P/E, Kimberly-Clark Corporation is actually cheaper at 13. 2x.

Over the past 5 years, The Procter & Gamble Company (PG) delivered a total return of +23.

8%, compared to -9. 5% for Kimberly-Clark Corporation (KMB). Over 10 years, the gap is even starker: PG returned +121. 5% versus KMB's +12. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), The Procter & Gamble Company (PG) is the lower-risk stock at 0.

10β versus Kimberly-Clark Corporation's 0. 14β — meaning KMB is approximately 37% more volatile than PG relative to the S&P 500. On balance sheet safety, The Procter & Gamble Company (PG) carries a lower debt/equity ratio of 68% versus 4% for Kimberly-Clark Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), The Procter & Gamble Company (PG) is pulling ahead at 0.

3% versus -14. 2% for Kimberly-Clark Corporation (KMB). On earnings-per-share growth, the picture is similar: The Procter & Gamble Company grew EPS 8. 1% year-over-year, compared to -19. 6% for Kimberly-Clark Corporation. Over a 3-year CAGR, PG leads at 1. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

The Procter & Gamble Company (PG) is the more profitable company, earning 19.

0% net margin versus 11. 7% for Kimberly-Clark Corporation — meaning it keeps 19. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PG leads at 24. 3% versus 14. 5% for KMB. At the gross margin level — before operating expenses — PG leads at 51. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Kimberly-Clark Corporation (KMB) trades at 13.

2x forward P/E versus 21. 4x for The Procter & Gamble Company — 8. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KMB: 10. 9% to $110. 00.

All stocks in this comparison pay dividends.

Kimberly-Clark Corporation (KMB) offers the highest yield at 5. 0%, versus 2. 7% for The Procter & Gamble Company (PG).

For long-horizon retirement investors, The Procter & Gamble Company (PG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

10), 2. 7% yield, +121. 5% 10Y return). Both have compounded well over 10 years (PG: +121. 5%, KMB: +12. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: KMB is a mid-cap deep-value stock; PG is a large-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.